A Joint Venture to Seed Asian Hedge Funds

Arlington Group and Eurekahedge have formed a joint venture to provide seed capital and support to Asian hedge funds and Asian long-only absolute return funds. Arlington will commit seed capital to the individual funds while Eurekahedge will provide origination, analytical support and the full resources of its globally based capital introduction team (New York, Geneva, Zurich, London, Tokyo, Hong Kong and Singapore). Richard Armstrong, one of Eurekahedge's founding partners and Joseph McCarthy, Arlington's Asia-focused investment manager, will jointly be responsible for managing and developing the seeding platform.

"This marks an exciting step in the development of Arlington Group and its target of expanding its interests in Asia," commented Nicholas Barham, Chairman of Arlington Group. "We believe that in Eurekahedge we have found a unique partner with a demonstrable depth of understanding and knowledge of Asian Funds and a proven track record in helping to support and raise capital for start-up funds".

Richard Armstrong says, "Early-stage capital is key to helping funds to develop. The joint venture with Arlington Group complements our existing services in start-up advisory, capital raising and hedge fund hotel. We are now able to provide the complete platform for funds to set up and grow. We are delighted that Arlington Group has chosen Eurekahedge as its local partner given their team's understanding of the alternative investment space and ability to execute quickly on investment decisions".

Arlington Group

Arlington Group Limited (LSE: ARL) is an investment company listed on the Alternative Investment Exchange (AIM) in London.


Eurekahedge is a leading alternative investment consultancy company focusing on research, publications and capital introduction. It was founded in 2001 and currently employs 60 people in Singapore, Hong Kong, London and New York. With a database of over 7000 hedge funds and over 150 hedge fund indices, Eurekahedge is one of the most widely used and quoted alternative research houses worldwide.

For more information, please contact:

Alexander Mearns
+65 6212 0924

Joseph McCarthy
+65 6212 0900